Aberrant activation of GLI1 is indeed associated with numerous human cancers, including glioma, medulloblastoma (MB), osteosarcoma, rhabdomyosarcoma and colorectal cancer [6, 8]. This evidence concerns the gene GLI1 and medulloblastoma.